Michael (Mike) Murphy is Director, Real-World Evidence & HEOR Strategy at Magnolia Market Access. Mike has nearly 15 years of experience using real-world data to generate evidence for payers, providers, governments, and life sciences companies.
Mike has deep expertise with study design and analytic methods to address bias and confounding in observational studies. He has used a variety of real-world databases to conduct burden of illness, comparative effectiveness, and drug safety studies. He has also performed Medicare reimbursement and policy analysis and has an enthusiasm for using visualization techniques to explore data and communicate insights.
Prior to joining Magnolia, Mike was a data scientist for Genesis Research, supporting RWE studies for pharmaceutical clients. He was also the analytics lead for Boston Scientific’s endoscopy, urology, and neuromodulation franchises and an analyst at the Harvard Pilgrim Health Care Institute supporting drug safety studies and research on hospital acquired infections. He is a co-author on 20+ peer-reviewed journal articles and dozens of conference abstracts.
Mike holds a Bachelor of Arts in history from Northeastern University.